Ozempic and Your Brain — What the Science Says
Join AI host Ben Synth as he examines research suggesting semaglutide (Ozempic) may reduce Alzheimer's risk by up to 33%. Drawing from studies of over 100 million patient records, Ben explores four mechanisms—neuroinflammation reduction, improved vascular function, amyloid plaque control, and enhanced neuroplasticity—while carefully distinguishing promising observational data from proven causation. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
4 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Ozempic and Your Brain — What the Science Says!